stars 1 stars 2 stars 3

Daval are the inventors and manufacturers of an audio based antiemetic programme, proven by clinical trial to have astounding levels of efficacy in dealing with the symptoms of nausea and vomiting. Our web site is to help promote and advertise the products as well as provide quick easy access to the research data submitted to us by the credible research authorities and bodies who have independently researched our product. Our antiemetic product is sold under the brand names of Nevasic and MorningWell, and has been changing the way medical professionals think of emesis for a number of years. Pregnancy & Morning Sickness- NHS research proves conclusively that our product is successful in relieving morning sickness in over 90% of all instances. Motion Sickness- in clinical trial the MRC Spatial Disorientation Group, Imperial College of Medicine, Westminster, London our programme was highly successful for relieving Travel Sickness. A clinical trial with Radio and Chemotherapy patients has been completed by CECO (Manchester University) and the results are highly motivating. Our programme has been registered with the MHRA and the FDA as a class 1 medical device, and is available as an app download from iTunes and Android stores under the Nevasic brand name.

Daval Ltd Questions

The Daval Ltd annual revenue was $1 million in 2026.

1 people are employed at Daval Ltd.

Daval Ltd is based in Sherborne St. John Ward, Hampshire.

The NAICS codes for Daval Ltd are [33, 339].

The SIC codes for Daval Ltd are [38, 384].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users